Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Tralokinumab in combination with topical corticosteroids in Japanese patients with moderate-to-severe Atopic Dermatitis; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2022-09-22